SlIde Sets

Explore slide sets below to learn more about dolutegravir and Dovato (dolutegravir/lamivudine)

DOVATO

TANGO subgroup analysis (CROI 2021)

A summary of the data presented at CROI 2021 from the TANGO on the 96 week subgroup data.

View slides

DOVATO

GEMINI 1&2 subgroup analysis (CROI 2021)

A summary of the data presented at CROI 2021 from the GEMINI 1&2 studies on the 144 week subgroup data.

View slides

DOVATO

GEMINI 1&2 144 week study - HIV Glasgow 2020 Presentation

Learn more about the latest GEMINI 1&2 144 Week study data for Dovato

View slides

DOVATO

Real-world data from URBAN study - HIV Glasgow 2020 Presentation

Learn more about the latest Real-world data from URBAN study for Dovato

View slides

DOVATO

TANGO 96 week - HIV Glasgow 2020 Presentation

Learn more about the latest TANGO 96 Week study for Dovato

View slides

DOVATO

European webinar: Dr Jean Van Wyk on TANGO metabolic parameters

Catch up on ViIV European webinar: Dr Jean Van Wyk presentation on TANGO 48 week metabolic parameters

View slides

DOVATO

European webinar: Prof. José Gatell on AIDS 2020

Catch up on ViIV European webinar: Prof. José Gatell on AIDS 2020

View slides

DOVATO

TANGO 48 Week Blips Presentation

Learn more about the TANGO 48 Week Blips study for Dovato

View slides

DOVATO

TANGO 48 Week Subgroup Analysis Presentation

Learn more about the TANGO 48 Week Subgroup Analysis study for Dovato

View slides

Other resources

Resources

Watch experts in HIV share the details of Dovato studies and watch internal and external experts share their opinions on the latest data.

Resources

Download bite-size infographics on the latest studies and data to help inform your HIV practice.

PM-GB-HVX-WCNT-200021 | April 2021